PulseMedica, an Edmonton, Canada-based life sciences startup, raised an aggregate of $12M.
The round was led by Saltagen Ventures with participation from Accelerate Fund III, ScaleGood Fund, ThresholdImpact, UCeed Health Fund, Startup TNT and the University of Alberta’s Innovation Fund.
The company intends to use the funds to accelerate the clinical validation of its floater imaging device.
Led by CEO Dr. Nir Katchinskiy PulseMedica is developing an ophthalmic medical device platform for non-invasive, automated image-guided laser treatment enabled by 3D computer vision, real-time tracking, and femtosecond laser technology.
FinSMEs
16/07/2024